Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial
Author:
Affiliation:
1. Merck & Co., Inc.; Kenilworth NJ USA
Funder
Merck
Publisher
Hindawi Limited
Subject
General Medicine
Reference40 articles.
1. The number of people with glaucoma worldwide in 2010 and 2020;Quigley;Br J Ophthalmol,2006
2. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial;Heijl;Arch Ophthalmol,2002
3. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial;Leske;Arch Ophthalmol,2003
4. Side effects associated with prostaglandin analog therapy;Alm;Surv Ophthalmol,2008
5. Primary open-angle glaucoma;Weinreb;Lancet,2004
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of preserved Tafluprost 0.0015% in lowering intraocular pressure;Indian Journal of Ophthalmology;2023-11-20
2. Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability;Expert Opinion on Drug Safety;2022-10-03
3. A Narrative Review of Ocular Surface Disease Related to Anti-Glaucomatous Medications;Ophthalmology and Therapy;2022-08-09
4. Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in China;BMC Ophthalmology;2022-08-05
5. Review of the measurement and management of 24-hour intraocular pressure in patients with glaucoma;Survey of Ophthalmology;2020-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3